MoonLake Immunotherapeutics (MLTX) Most Active Options

The 25 most actively traded MoonLake Immunotherapeutics (MLTX) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$20.63
52-week range
$6.25 – $61.95
ATM IV (30d)
108.5%
IV rank
65 / 100
Moderate
Expected move
±$3.10 (±15.0%)
Put/call OI
0.24
Call-heavy
Max pain
$18
↓ 12.8% below close
Next earnings
Aug 9, 2026

Most Active MLTX Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
MLTX $24 call Nov 20, 2026 133d $4.00 99.5% 48 0.52 1,004 1,021 46.4× avg
MLTX $45 call Jan 15, 2027 189d $1.15 93.9% 24 0.21 106 401 36.1× avg
MLTX $80 call Jan 15, 2027 189d $0.50 107.3% 50 0.09 173 203 18.3× avg
MLTX $20 call Aug 21, 2026 42d $3.50 117.2% 90 0.60 2,918 150 7.6× avg
MLTX $30 call Jul 17, 2026 7d $0.10 163.6% 0 0.06 348 114 8.8× avg
MLTX $26 call Jul 17, 2026 7d $0.15 126.5% 11 0.10 25 93 6.4× avg
MLTX $20 call Jan 15, 2027 189d $6.20 94.5% 47 0.65 729 70 23.6× avg
MLTX $25 call Jul 17, 2026 7d $0.20 124.7% 10 0.14 294 60 4.1× avg
MLTX $19 call Jul 17, 2026 7d $2.00 119.7% 100 0.69 147 58 3.4× avg
MLTX $35 call Aug 21, 2026 42d $0.40 109.7% 26 0.10 1,539 46 1.8× avg
MLTX $23 call Jul 17, 2026 7d $0.58 118.6% 89 0.26 271 32 2.3× avg
MLTX $15 put Aug 21, 2026 42d $0.82 114.0% 71 -0.16 378 31 13.2× avg
MLTX $28 call Jul 17, 2026 7d $0.10 186.9% 66 0.14 0 29 2.0× avg
MLTX $22 call Aug 21, 2026 42d $2.80 104.0% 53 0.49 177 27 0.2× avg
MLTX $21 call Jul 17, 2026 7d $1.30 108.5% 100 0.45 107 26 1.6× avg
MLTX $17 call Jul 17, 2026 7d $3.50 122.1% 100 0.88 16 17 4.4× avg
MLTX $30 call Aug 21, 2026 42d $0.85 111.6% 27 0.21 511 16 0.6× avg
MLTX $22 call Jul 17, 2026 7d $0.75 96.9% 50 0.31 1,072 16 1.2× avg
MLTX $17 put Jul 17, 2026 7d $0.20 137.8% 12 -0.15 89 14 5.9× avg
MLTX $20 put Jul 17, 2026 7d $0.85 110.3% 100 -0.42 303 13 1.4× avg
MLTX $21 call Aug 21, 2026 42d $2.80 108.7% 68 0.54 3,125 12 0.2× avg
MLTX $30 call Jan 15, 2027 189d $3.20 90.2% 17 0.40 3,621 12 1.1× avg
MLTX $27 call Jul 17, 2026 7d $0.10 145.8% 29 0.10 1 11 0.8× avg
MLTX $28 call Aug 21, 2026 42d $1.00 104.0% 42 0.24 24 11 0.5× avg
MLTX $5 call Jan 21, 2028 560d $17.30 99.3% 36 0.96 93 11 14.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active MLTX contract today is the $24 call expiring in 133 days, with 1,021 contracts traded. Calls dominate the most-active list (22 of the top 25), showing where trading interest concentrates. One of these contracts is running well ahead of the usual daily volume.

Explore the payoff profile of option on MLTX for free

Build multi-leg MLTX strategies, visualize payoffs, and scan the full US options universe with OptiView.

MLTX Options FAQ

Which MLTX option contract is most active today?

The most traded MLTX contract is the $24 call expiring Nov 20, 2026, with 1,021 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active MLTX options?

The table lists the 25 MLTX contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.